A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, ...

"Most of the time we undertreat," says expert ...

Iza-bren improved survival and delayed disease progression versus chemotherapy in previously treated metastatic ...

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.

This article was medically reviewed by Lisa Richards, MSN, CNM, who offers health services at Ovia Health. Triple-negative breast cancer is an aggressive cancer that's primarily treated with ...

With the numerous policy promises being made to advance health equity, it is past time for lawmakers in Washington to double down on policies proven to save lives of undersupported groups who bear the ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a new computational approach designed to better account for changes in gene expression within tumors relative to their ...

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...

Please provide your email address to receive an email when new articles are posted on . First-line sacituzumab govitecan significantly improved PFS for metastatic triple-negative breast cancer subset ...